IP Library › Granted Patent US 10,669,595
Granted Patent B2
US 10,669,595 · App. 15/377,638 · Granted Jun 2, 2020

Oligonucleotide primer composition

Inventor: Astrid R. W. Schroder (Encinitas, CA)
Assignee: GEN-PROBE INCORPORATED
C12Q1/703C12Q1/6851C12Q1/6865C12Q2600/156
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,669,595
App. No.
15/377,638
Granted
Jun 2, 2020
Kind
B2
Abstract

Oligonucleotide primer useful for synthesizing a cDNA copy of HIV-1 nucleic acids from a broad range of HIV-1 subtypes, including M group and O group variants.

Claims (5)

1. A composition comprising an oligonucleotide primer, the base sequence of said oligonucleotide primer consisting of SEQ ID NO:19.

2. The composition of claim 1 , further comprising a reverse transcriptase enzyme, and deoxyribonucleotide triphosphates.

3. The composition of claim 2 , wherein the reverse transcriptase enzyme is MMLV reverse-transcriptase.

4. The composition of claim 2 , further comprising ribonucleotide triphosphates.

5. The composition of claim 4 , further comprising T7 RNA polymerase.

Assignments (5)
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 054089/0804 Recorded Apr 28, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC., ON ITS OWN BEHALF AND AS SUCCESSOR-BY-MERGER TO FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED; FAXITRON BIOPTICS, LLC; GEN-PROBE PRODESSE, INC.
Reel/Frame 075504/0575 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 041050/0285 Recorded Apr 23, 2026
From: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
To: HOLOGIC, INC.; GEN-PROBE INCORPORATED
Reel/Frame 075455/0001 →
SECURITY INTEREST Recorded Apr 8, 2026
From: BIOTHERANOSTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; CYTYC CORPORATION; SUROS SURGICAL SYSTEMS, INC.; GYNESONICS, INC.; BOLDER SURGICAL, LLC; FAXITRON BIOPTICS, LLC; HEALTH BEACONS, INC.; HOLOGIC, INC.
To: ROYAL BANK OF CANADA, AS COLLATERAL AGENT
Reel/Frame 075462/0440 →
SECURITY INTEREST Recorded Oct 15, 2020
From: HOLOGIC, INC.; FAXITRON BIOPTICS, LLC; FOCAL THERAPEUTICS, INC.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 054089/0804 →
SECURITY INTEREST Recorded Jan 23, 2017
From: HOLOGIC, INC.; GEN-PROBE INCORPORATED
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 041050/0285 →
Continuity (5)
Continuation 13678317 · Nov 15, 2012
Continuation 13245483 · Sep 26, 2011
Continuation 11240046 · Sep 30, 2005
Provisional Application 60615533 · Sep 30, 2004
Related Publication 20170088906A1 · Mar 30, 2017